{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:20:52Z","timestamp":1792790452600,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T00:00:00Z","timestamp":1424995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12889-015-1514-y","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T07:04:10Z","timestamp":1424934250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["The humanistic, economic and societal burden of Herpes Zoster in Europe: a critical review"],"prefix":"10.1186","volume":"15","author":[{"given":"Adam","family":"Gater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Uhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"McCool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Pr\u00e9aud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,27]]},"reference":[{"issue":"3","key":"1514_CR1","first-page":"373","volume":"54","author":"W Opstelten","year":"2008","unstructured":"Opstelten W, Eekhof J, Neven AK, Verheij T. Treatment of herpes zoster. Can Fam Phys Med Fam Can. 2008;54(3):373\u20137.","journal-title":"Can Fam Phys Med Fam Can"},{"issue":"1","key":"1514_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00431-007-0424-0","volume":"167","author":"N Sengupta","year":"2008","unstructured":"Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P, Schumacher RF, et al. Varicella vaccination in Europe: are we ready for a universal childhood programme? Eur J Pediatr. 2008;167(1):47\u201355.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"1514_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-170","volume":"13","author":"S Pinchinat","year":"2013","unstructured":"Pinchinat S, Cebri\u00e1n-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13(1):1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 2","key":"1514_CR4","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1086\/522152","volume":"197","author":"K Schmader","year":"2008","unstructured":"Schmader K, Gnann Jr JW, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008;197 Suppl 2:S207\u201315.","journal-title":"J Infect Dis"},{"issue":"390","key":"1514_CR5","first-page":"39","volume":"45","author":"T Lancaster","year":"1995","unstructured":"Lancaster T, Silagy C, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract. 1995;45(390):39\u201345.","journal-title":"Br J Gen Pract"},{"key":"1514_CR6","volume-title":"The epidemiology and natural history of herpes zoster and postherpetic neuralgia","author":"R Dworkin","year":"2001","unstructured":"Dworkin R, Schmander K. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. 2nd ed. Amsterdam: Elsevier; 2001.","edition":"2"},{"issue":"9","key":"1514_CR7","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","volume":"24","author":"FT Scott","year":"2006","unstructured":"Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J. The burden of Herpes Zoster: a prospective population based study. Vaccine. 2006;24(9):1308\u201314.","journal-title":"Vaccine"},{"issue":"1\u20132","key":"1514_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pain.2006.10.024","volume":"128","author":"RW Johnson","year":"2007","unstructured":"Johnson RW, Rice AS. Pain following herpes zoster: the influence of changing population characteristics and medical developments. Pain. 2007;128(1\u20132):3\u20135.","journal-title":"Pain"},{"issue":"11","key":"1514_CR9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1586\/14737175.7.11.1581","volume":"7","author":"RW Johnson","year":"2007","unstructured":"Johnson RW, Wasner G, Saddier P, Baron R. Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother. 2007;7(11):1581\u201395.","journal-title":"Expert Rev Neurother"},{"issue":"864","key":"1514_CR10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/pgmj.73.864.623","volume":"73","author":"D Bowsher","year":"1997","unstructured":"Bowsher D. The management of postherpetic neuralgia. Postgrad Med J. 1997;73(864):623\u20139.","journal-title":"Postgrad Med J"},{"issue":"22","key":"1514_CR11","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271\u201384.","journal-title":"N Engl J Med"},{"issue":"7264","key":"1514_CR12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","volume":"321","author":"S Helgason","year":"2000","unstructured":"Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ. 2000;321(7264):794\u20136.","journal-title":"BMJ"},{"issue":"1","key":"1514_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM199607043350107","volume":"335","author":"RG Kost","year":"1996","unstructured":"Kost RG, Straus SE. Postherpetic neuralgia\u2013pathogenesis, treatment, and prevention. N Engl J Med. 1996;335(1):32\u201342.","journal-title":"N Engl J Med"},{"issue":"1","key":"1514_CR14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1477-7525-12-92","volume":"12","author":"M Serpell","year":"2014","unstructured":"Serpell M, Gater A, Carroll S, Abetz-Webb L, Mannan A, Johnson R. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: Findings from the zoster quality of life (ZQOL) study. Health Qual Life Outcomes. 2014;12(1):92.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"1514_CR15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pain.2011.10.026","volume":"153","author":"D Bouhassira","year":"2012","unstructured":"Bouhassira D, Chassany O, Gaillat J, Hanslik T, Launay O, Mann C, et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain. 2012;153(2):342\u20139.","journal-title":"Pain"},{"issue":"11","key":"1514_CR16","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.1997.00440320117011","volume":"157","author":"PW Choo","year":"1997","unstructured":"Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk factors for postherpetic neuralgia. Arch Intern Med. 1997;157(11):1217\u201324.","journal-title":"Arch Intern Med"},{"issue":"8","key":"1514_CR17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ejpain.2005.11.002","volume":"10","author":"PG Coen","year":"2006","unstructured":"Coen PG, Scott F, Leedham-Green M, Nia T, Jamil A, Johnson RW, et al. Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice? Eur J Pain. 2006;10(8):695\u2013700.","journal-title":"Eur J Pain"},{"issue":"5","key":"1514_CR18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","volume":"19","author":"W Opstelten","year":"2002","unstructured":"Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19(5):471\u20135.","journal-title":"Fam Pract"},{"issue":"Suppl 1","key":"1514_CR19","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.pain.2007.02.004","volume":"132","author":"W Opstelten","year":"2007","unstructured":"Opstelten W, Zuithoff NP, van Essen GA, van Loon AM, van Wijck AJ, Kalkman CJ, et al. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain. 2007;132 Suppl 1:S52\u20139.","journal-title":"Pain"},{"issue":"6","key":"1514_CR20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/AJP.0b013e318065b6c9","volume":"23","author":"KE Schmader","year":"2007","unstructured":"Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23(6):490\u20136.","journal-title":"Clin J Pain"},{"issue":"1","key":"1514_CR21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1086\/320884","volume":"33","author":"C Chidiac","year":"2001","unstructured":"Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplege A, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2001;33(1):62\u20139.","journal-title":"Clin Infect Dis: Offic Publ Infect Dis Soc Am"},{"issue":"16","key":"1514_CR22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ: Can Med Assoc J\u2009=\u2009J Assoc Med Can. 2010;182(16):1731\u20136.","journal-title":"CMAJ: Can Med Assoc J\u2009=\u2009J Assoc Med Can"},{"issue":"3","key":"1514_CR23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/421942","volume":"39","author":"J Katz","year":"2004","unstructured":"Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2004;39(3):342\u20138.","journal-title":"Clin Infect Dis: Offic Publ Infect Dis Soc Am"},{"issue":"6","key":"1514_CR24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","volume":"6","author":"G Oster","year":"2005","unstructured":"Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005;6(6):356\u201363.","journal-title":"J Pain"},{"issue":"2","key":"1514_CR25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ageing\/afj048","volume":"35","author":"R Seventer van","year":"2006","unstructured":"van Seventer R, Sadosky A, Lucero M, Dukes E. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing. 2006;35(2):132\u20137.","journal-title":"Age Ageing"},{"issue":"3","key":"1514_CR26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3111\/13696998.2010.502854","volume":"13","author":"L Annemans","year":"2010","unstructured":"Annemans L, Bresse X, Gobbo C, Papageorgiou M. Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium. J Med Econ. 2010;13(3):537\u201351.","journal-title":"J Med Econ"},{"issue":"1","key":"1514_CR27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2334-11-302","volume":"11","author":"A Cebri\u00e1n-Cuenca","year":"2011","unstructured":"Cebri\u00e1n-Cuenca A, D\u00edez-Domingo J, San-Mart\u00edn-Rodr\u00edguez M, Puig-Barber\u00e1 J, Navarro-P\u00e9rez J. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian Community of Spain. BMC Infect Dis. 2011;11(1):302.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1514_CR28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","volume":"137","author":"A Gauthier","year":"2009","unstructured":"Gauthier A, Breuer J, Carrington D, Martin M, Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38\u201347.","journal-title":"Epidemiol Infect"},{"key":"1514_CR29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-10-230","volume":"10","author":"LE Gialloreti","year":"2010","unstructured":"Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1514_CR30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.respe.2010.06.166","volume":"58","author":"G Mick","year":"2010","unstructured":"Mick G, Gallais JL, Simon F, Pinchinat S, Bloch K, Beillat M, et al. [Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over]. Rev Epidemiol Sante Publique. 2010;58(6):393\u2013401.","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"6","key":"1514_CR31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","volume":"14","author":"B Ultsch","year":"2012","unstructured":"Ultsch B, Koster I, Reinhold T, Siedler A, Krause G, Icks A, et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ: HEPAC: Health Econ Prev Care. 2012;14(6):1015\u201326.","journal-title":"Eur J Health Econ: HEPAC: Health Econ Prev Care"},{"issue":"10","key":"1514_CR32","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/514342","volume":"44","author":"MB Rothberg","year":"2007","unstructured":"Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2007;44(10):1280\u20138.","journal-title":"Clin Infect Dis: Offic Publ Infect Dis Soc Am"},{"issue":"7","key":"1514_CR33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","volume":"54","author":"KE Schmader","year":"2012","unstructured":"Schmader KE, Levin MJ, Gnann Jr JW, McNeil SA, Vesikari T, Betts RF, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years. Clin Infect Dis. 2012;54(7):922\u20138.","journal-title":"Clin Infect Dis"},{"key":"1514_CR34","unstructured":"Collaboration TC: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: Available from www.cochrane-handbook.org ; 2011."},{"key":"1514_CR35","series-title":"The Cochrane Collaboration","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"GS Higgins JPT","year":"2011","unstructured":"Higgins JPT GS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011], The Cochrane Collaboration. 2011."},{"key":"1514_CR36","volume-title":"Harmonised Index of Consumer Prices","author":"Eurostat","year":"2014","unstructured":"Eurostat. Harmonised Index of Consumer Prices. 2014."},{"issue":"4","key":"1514_CR37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1576-9887(11)70019-X","volume":"12","author":"J Bayas","year":"2011","unstructured":"Bayas J, Gil R, Llupi\u00e1 A, D\u00edez C, Conesa A, Ariza C, et al. Hospitalizaciones por herpes zoster y neuralgia postherp\u00e9tica en Catalu\u00f1a, 1998\u20132003. Vacunas. 2011;12(4):122\u20138.","journal-title":"Vacunas"},{"key":"1514_CR38","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.eurger.2013.07.381","volume":"4","author":"G Berrut","year":"2013","unstructured":"Berrut G, Baptiste C. Ophthalmic herpes zoster, a complication with a poor prognosis, is now a vaccine-preventable disease. Eur Geriatr Med. 2013;4:S116.","journal-title":"Eur Geriatr Med"},{"issue":"7","key":"1514_CR39","doi-asserted-by":"crossref","first-page":"A503","DOI":"10.1016\/j.jval.2013.08.1151","volume":"16","author":"C Blein","year":"2013","unstructured":"Blein C, Gavazzi G, Paccalin M, Baptiste C, Vainchtock A. Evaluation of the herpes zoster impact as comorbidity factor in 5 pathologies French hospital care among adults aged 50 and older. Value Health: J Int Soc Pharmacoeconomics Outcomes Res. 2013;16(7):A503.","journal-title":"Value Health: J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"11","key":"1514_CR40","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","volume":"140","author":"J Bilcke","year":"2012","unstructured":"Bilcke J, Ogunjimi B, Marais C, de Smet F, Callens M, Callaert K, et al. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect. 2012;140(11):2096\u2013109.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"1514_CR41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/erp.13.19","volume":"13","author":"X Bresse","year":"2013","unstructured":"Bresse X, Annemans L, Preaud E, Bloch K, Duru G, Gauthier A. Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis. Expert Rev Pharmacoeconomics Outcomes Res. 2013;13(3):393\u2013406.","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"},{"key":"1514_CR42","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.eurger.2013.07.383","volume":"4","author":"H Bricout","year":"2013","unstructured":"Bricout H, Perinetti E, Marchettini P, Ragni P, Zotti C, Gabutti G, et al. Description of herpes zoster patients aged over 50 years in Italy-A GP based multi center prospective observational study. Eur Geriatr Med. 2013;4:S116\u20137.","journal-title":"Eur Geriatr Med"},{"issue":"10","key":"1514_CR43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/adc.88.10.862","volume":"88","author":"M Brisson","year":"2003","unstructured":"Brisson M, Edmunds WJ. Varicella vaccination in England and Wales: cost-utility analysis. Arch Dis Child. 2003;88(10):862\u20139.","journal-title":"Arch Dis Child"},{"key":"1514_CR44","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.eurger.2013.07.260","volume":"4","author":"JM Castro-Lopes","year":"2013","unstructured":"Castro-Lopes JM, Menezes J, Mendonca L, Costa-Pereira A, Azevedo L. The impact of post-herpetic neuralgia: a prospective multicentre study on pain and health related quality of life. Eur Geriatr Med. 2013;4:S79.","journal-title":"Eur Geriatr Med"},{"issue":"4","key":"1514_CR45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1576-9887(11)70020-6","volume":"12","author":"J Juanes de","year":"2011","unstructured":"de Juanes J, Arrazola P, Garc\u00eda de Codes A, Ariza C, Gil R, San Mart\u00edn M, et al. Hospitalizaciones por herpes zoster y neuralgia postherp\u00e9tica en la Comunidad de Madrid, 1998\u20132003. Vacunas. 2011;12(4):129\u201335.","journal-title":"Vacunas"},{"issue":"43","key":"1514_CR46","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.vaccine.2007.07.049","volume":"25","author":"V Legami Di","year":"2007","unstructured":"Di Legami V, Gianino MM, Ciofi degli Atti M, Massari M, Migliardi A, Tomba GS, et al. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine. 2007;25(43):7598\u2013604.","journal-title":"Vaccine"},{"issue":"23\u201324","key":"1514_CR47","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","volume":"19","author":"WJ Edmunds","year":"2001","unstructured":"Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001;19(23\u201324):3076\u201390.","journal-title":"Vaccine"},{"key":"1514_CR48","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.eurger.2013.07.379","volume":"4","author":"E Franco","year":"2013","unstructured":"Franco E, Perinetti E, Marchettini P, Ragni P, Zotti C, Gabutti G, et al. Proportion of post herpetic neuralgia among patients with herpes zoster in Italy-A multicenter prospective observational study. Eur Geriatr Med. 2013;4:S115\u20136.","journal-title":"Eur Geriatr Med"},{"issue":"10","key":"1514_CR49","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/ard.2009.125658","volume":"69","author":"I Garc\u00eda-Doval","year":"2010","unstructured":"Garc\u00eda-Doval I, P\u00e9rez-Zafrilla B, Descalzo M\u00c1, Rosell\u00f3 R, Hern\u00e1ndez MV, G\u00f3mez-Reino JJ, et al. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis. 2010;69(10):1751\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1514_CR50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/1471-2334-14-402","volume":"14","author":"A Gater","year":"2014","unstructured":"Gater A, Abetz-Webb L, Carroll S, Mannan A, Serpell M, Johnson R. Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis. 2014;14(1):402.","journal-title":"BMC Infect Dis"},{"issue":"29\u201330","key":"1514_CR51","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2004.04.004","volume":"22","author":"A Gil","year":"2004","unstructured":"Gil A, San-Martin M, Carrasco P, Gonzalez A. Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine. 2004;22(29\u201330):3947\u201351.","journal-title":"Vaccine"},{"key":"1514_CR52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-9-55","volume":"9","author":"A Gil","year":"2009","unstructured":"Gil A, Gil R, Alvaro A, San Martin M, Gonzalez A. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998\u20132004). BMC Infect Dis. 2009;9:55.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1514_CR53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1576-9887(11)70013-9","volume":"12","author":"R Gil-Prieto","year":"2011","unstructured":"Gil-Prieto R, San-Mart\u00edn M, \u00c1lvaro-Meca A, Gonz\u00e1lez-L\u00f3pez A, Gil de Miguel A. Herpes zoster hospitalizations of patients with chronic illnesses in Spain, 1998\u20132004. Vacunas. 2011;12(3):95\u2013101.","journal-title":"Vacunas"},{"issue":"2","key":"1514_CR54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2013.11.008","volume":"32","author":"R Gil-Prieto","year":"2014","unstructured":"Gil-Prieto R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, Marin-Garcia P, Gil-de-Miguel A. Different vaccination strategies in spain and its impact on severe varicella and zoster. Vaccine. 2014;32(2):277\u201383.","journal-title":"Vaccine"},{"issue":"50","key":"1514_CR55","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","volume":"28","author":"S Gonzalez Chiappe","year":"2010","unstructured":"Gonzalez Chiappe S, Sarazin M, Turbelin C, Lasserre A, Pelat C, Bonmarin I, et al. Herpes zoster: Burden of disease in France. Vaccine. 2010;28(50):7933\u20138.","journal-title":"Vaccine"},{"issue":"1","key":"1514_CR56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2296-12-136","volume":"12","author":"CD Lionis","year":"2011","unstructured":"Lionis CD, Vardavas CI, Symvoulakis EK, Papadakaki MG, Anastasiou FS, Antonopoulou MD, et al. Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece. BMC Fam Pract. 2011;12(1):136.","journal-title":"BMC Fam Pract"},{"issue":"2","key":"1514_CR57","first-page":"527","volume":"37","author":"Z Loncar","year":"2013","unstructured":"Loncar Z, Mestrovic AH, Bilic M, Taksic I, Mickovic V. Quality of pain in herpes zoster patients Kvaliteta boli kod pacijenata oboljelih od herpes zostera. Coll Antropol. 2013;37(2):527\u201330.","journal-title":"Coll Antropol"},{"issue":"4","key":"1514_CR58","first-page":"441","volume":"20","author":"K Lukas","year":"2012","unstructured":"Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. Zeitschr Gesundheitswissenschaften\u2009=\u2009J Public Health. 2012;20(4):441\u201351.","journal-title":"Zeitschr Gesundheitswissenschaften\u2009=\u2009J Public Health"},{"issue":"5","key":"1514_CR59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.20344\/amp.312","volume":"26","author":"M Mesquita","year":"2013","unstructured":"Mesquita M, Froes F. Hospital admissions for Herpes Zoster in Portugal between 2000 and 2010 Internamentos hospitalares por Herpes Zoster em Portugal entre 2000 e 2010. Acta Med Port. 2013;26(5):531\u20136.","journal-title":"Acta Med Port"},{"key":"1514_CR60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-7547-8-7","volume":"8","author":"L Moore","year":"2010","unstructured":"Moore L, Remy V, Martin M, Beillat M, McGuire A. A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK. Cost Effect Resour Allocation: C\/E. 2010;8:7.","journal-title":"Cost Effect Resour Allocation: C\/E"},{"issue":"1","key":"1514_CR61","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/1471-2334-13-463","volume":"13","author":"N Morant-Talamante","year":"2013","unstructured":"Morant-Talamante N, Diez-Domingo J, Martinez-Ubeda S, Puig-Barbera J, Aleman-Sanchez S, Perez-Breva L. Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). BMC Infect Dis. 2013;13(1):463.","journal-title":"BMC Infect Dis"},{"issue":"suppl 8","key":"1514_CR62","first-page":"31","volume":"60","author":"S Mordarski","year":"2009","unstructured":"Mordarski S, Lysenko L, Gerber H, Zietek M, Gredes T, Dominiak M. The effect of treatment with fentanyl patches on pain relief and improvement in overall daily functioning in patients with postherpetic neuralgia. J Physiol Pharmacol. 2009;60 suppl 8:31\u20135.","journal-title":"J Physiol Pharmacol"},{"issue":"7","key":"1514_CR63","doi-asserted-by":"crossref","first-page":"A347","DOI":"10.1016\/j.jval.2013.08.147","volume":"16","author":"J Nilsson","year":"2013","unstructured":"Nilsson J, Cassel T, Lindquist L. Burden of herpes zoster and post-herpetic neuralgia in Sweden. Value Health. 2013;16(7):A347.","journal-title":"Value Health"},{"key":"1514_CR64","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2334-12-110","volume":"12","author":"JG Pierik","year":"2012","unstructured":"Pierik JG, Gumbs PD, Fortanier SA, Van Steenwijk PC, Postma MJ. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis. 2012;12:110.","journal-title":"BMC Infect Dis"},{"issue":"11\u201312","key":"1514_CR65","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.medmal.2013.07.012","volume":"43","author":"C Rabaud","year":"2013","unstructured":"Rabaud C, Rogeaux O, Launay O, Strady C, Mann C, Chassany O, et al. Early antiviral treatment fails to completely prevent herpes-related pain. Med Mal Infect. 2013;43(11\u201312):461\u20136.","journal-title":"Med Mal Infect"},{"issue":"7","key":"1514_CR66","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1185\/03007995.2010.483675","volume":"26","author":"S Rehm","year":"2010","unstructured":"Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin. 2010;26(7):1607\u201319.","journal-title":"Curr Med Res Opin"},{"issue":"04","key":"1514_CR67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0029-1245896","volume":"16","author":"J Schiffner-Rohe","year":"2011","unstructured":"Schiffner-Rohe J, K\u00f6ster I, Beillat M, Lilie H, Schubert I. Resource consumption and health care costs of herpes zoster and postherpetic neuralgia in Germany. Gesundheits\u00f6konomie Qualit\u00e4tsmanagement. 2011;16(04):216\u201323.","journal-title":"Gesundheits\u00f6konomie Qualit\u00e4tsmanagement"},{"issue":"Suppl 1","key":"1514_CR68","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1002\/jmv.10316","volume":"70","author":"FT Scott","year":"2003","unstructured":"Scott FT, Leedham-Green ME, Barrett-Muir WY, Hawrami K, Gallagher WJ, Johnson R, et al. A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol. 2003;70 Suppl 1:S24\u201330.","journal-title":"J Med Virol"},{"issue":"8","key":"1514_CR69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.33588\/rn.5508.2012298","volume":"55","author":"A Sicras-Mainar","year":"2012","unstructured":"Sicras-Mainar A, Navarro-Artieda R, Ib\u00e1\u00f1ez-Nolla J, Perez-Ronco J. [Incidence, resource use and costs associated with postherpetic neuralgia: a population-based retrospective study]. Rev Neurol. 2012;55(8):449\u201361.","journal-title":"Rev Neurol"},{"key":"1514_CR70","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.eurger.2013.07.386","volume":"4","author":"K Souliotis","year":"2013","unstructured":"Souliotis K, Lionis C, Papadakaki M, Papageorgiou M, Tsiaousi I, Bersimis S. The economic burden of herpes zoster on patients visiting primary care settings in Greece-Results from a multicentre study in Crete. Eur Geriatr Med. 2013;4:S117\u20138.","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"1514_CR71","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2334-13-586","volume":"13","author":"M Studahl","year":"2013","unstructured":"Studahl M, Petzold M, Cassel T. Disease burden of herpes zoster in Sweden - predominance in the elderly and in women - a register based study. BMC Infect Dis. 2013;13(1):586.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"1514_CR72","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4161\/hv.7.7.15573","volume":"7","author":"TD Szucs","year":"2011","unstructured":"Szucs TD, Kressig RW, Papageorgiou M, Kempf W, Michel JP, Fendl A, et al. Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland. Hum Vaccine. 2011;7(7):749\u201356.","journal-title":"Hum Vaccine"},{"key":"1514_CR73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2334-11-173","volume":"11","author":"B Ultsch","year":"2011","unstructured":"Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"1514_CR74","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","volume":"27","author":"AJ Hoek van","year":"2009","unstructured":"van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ. Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine. 2009;27(9):1454\u201367.","journal-title":"Vaccine"},{"issue":"4","key":"1514_CR75","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcv.2007.01.010","volume":"38","author":"A Volpi","year":"2007","unstructured":"Volpi A, Gatti A, Serafini G, Costa B, Suligoi B, Pica F, et al. Clinical and psychosocial correlates of acute pain in herpes zoster. J Clin Virol: Offic Publ Pan Am Soc Clin Virol. 2007;38(4):275\u20139.","journal-title":"J Clin Virol: Offic Publ Pan Am Soc Clin Virol"},{"issue":"9","key":"1514_CR76","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jmv.21254","volume":"80","author":"A Volpi","year":"2008","unstructured":"Volpi A, Gatti A, Pica F, Bellino S, Marsella LT, Sabato AF. Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol. 2008;80(9):1646\u201352.","journal-title":"J Med Virol"},{"issue":"4","key":"1514_CR77","first-page":"367","volume":"18","author":"T Weinke","year":"2010","unstructured":"Weinke T, Edte A, Schmitt S, Lukas K. Impact of herpes zoster and post-herpetic neuralgia on patients\u2019 quality of life: a patient-reported outcomes survey. Zeitschr Gesundheitswissenschaften\u2009=\u2009J Public Health. 2010;18(4):367\u201374.","journal-title":"Zeitschr Gesundheitswissenschaften\u2009=\u2009J Public Health"},{"key":"1514_CR78","volume-title":"Active ageing: a policy framework","author":"Organization WH","year":"2002","unstructured":"Organization WH. Active ageing: a policy framework. 2002."},{"issue":"3 Suppl 1","key":"1514_CR79","first-page":"S8","volume":"107","author":"KE Galluzzi","year":"2007","unstructured":"Galluzzi KE. Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc. 2007;107(3 Suppl 1):S8\u201313.","journal-title":"J Am Osteopath Assoc"},{"issue":"Suppl 1","key":"1514_CR80","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S1386-6532(10)70005-6","volume":"48","author":"RJ Whitley","year":"2010","unstructured":"Whitley RJ, Volpi A, McKendrick M, Wijck A, Oaklander AL. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol: Offic Publ Pan Am Soc Clin Virol. 2010;48 Suppl 1:S20\u20138.","journal-title":"J Clin Virol: Offic Publ Pan Am Soc Clin Virol"},{"issue":"5","key":"1514_CR81","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00128071-200506050-00005","volume":"6","author":"A Volpi","year":"2005","unstructured":"Volpi A, Gross G, Hercogova J, Johnson RW. Current management of herpes zoster: the European view. Am J Clin Dermatol. 2005;6(5):317\u201325.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"1514_CR82","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4161\/hv.4.3.5686","volume":"4","author":"M Brisson","year":"2008","unstructured":"Brisson M, Pellissier JM, Camden S, Quach C, De Wals P. The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia. Hum Vaccine. 2008;4(3):238\u201345.","journal-title":"Hum Vaccine"},{"issue":"4","key":"1514_CR83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1533-2500.2010.00432.x","volume":"11","author":"G Pickering","year":"2011","unstructured":"Pickering G, Leplege A. Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly. Pain Pract: Offic J World Inst Pain. 2011;11(4):397\u2013402.","journal-title":"Pain Pract: Offic J World Inst Pain"},{"issue":"12","key":"1514_CR84","first-page":"A4345","volume":"58","author":"GL Mortensen","year":"2011","unstructured":"Mortensen GL. Perceptions of herpes zoster and attitudes towards zoster vaccination among 50-65-year-old Danes. Dan Med Bull. 2011;58(12):A4345.","journal-title":"Dan Med Bull"},{"key":"1514_CR85","unstructured":"Eurostat: Ageing Charaterises the Demographic Perspectives of the European Societies. Statistics in Focus Available at: http:\/\/ec.europa.eu\/eurostat\/en\/web\/products-statistics-in-focus\/-\/KS-SF-10-001 2008."},{"issue":"12","key":"1514_CR86","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4065\/mcp.2011.0724","volume":"86","author":"BP Yawn","year":"2011","unstructured":"Yawn BP. Post-shingles neuralgia by any definition is painful, but is it PHN? Mayo Clin Proc Mayo Clin. 2011;86(12):1141\u20132.","journal-title":"Mayo Clin Proc Mayo Clin"},{"issue":"5","key":"1514_CR87","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3111\/13696998.2011.607482","volume":"14","author":"PK Singhal","year":"2011","unstructured":"Singhal PK, Makin C, Pellissier J, Sy L, White R, Saddier P. Work and productivity loss related to herpes zoster. J Med Econ. 2011;14(5):639\u201345.","journal-title":"J Med Econ"},{"issue":"12","key":"1514_CR88","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.vaccine.2012.01.045","volume":"30","author":"M Drolet","year":"2012","unstructured":"Drolet M, Levin MJ, Schmader KE, Johnson R, Oxman MN, Patrick D, et al. Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. Vaccine. 2012;30(12):2047\u201350.","journal-title":"Vaccine"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-015-1514-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1514-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1514-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1514-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T01:54:42Z","timestamp":1747706082000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-015-1514-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,27]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1186\/s12889-015-1514-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,27]]},"article-number":"193"}}